Edgewise Therapeutics · 1 month ago
Senior Clinical Research Associate - Cardiovascular (EDG-2025017)
Edgewise Therapeutics is on a mission to discover new medicines that improve the lives of patients facing serious muscle disease. They are seeking a Senior Clinical Research Associate to lead site start-up activities, collaborate with internal teams, and ensure the successful execution of complex clinical trials.
BiopharmaBiotechnologyHealth Care
Responsibilities
Lead site start-up activities (e.g. oversight of CRO start-up activities, accountable for essential document package review, site initiation slide deck, vendor training, participate in remote/or on-site initiation visits) and contribute to feasibility, as required
Collaborate with contracts team to lead review and negotiation of site and vendor budgets/contracts
Contribute to the development and review of study, patient and site facing documents (e.g. protocols, ICFs and study plans)
Oversee Edgewise contract CRA and/or CRO monitoring activities (e.g. visit schedules, monitoring visit reviews, monitoring plan review). May include on-site co-monitoring with CRO CRA, ensuring compliance with protocol and regulatory requirements. Provide additional clinical monitoring training support to CRO personnel, as needed. Attend CRO monitoring meetings. May include assigned monitoring responsibilities for sites
Review and oversee site KPIs, protocol deviations and metrics to identify trends and maintain data quality. Escalate site level risks or non-compliance, and in collaboration with Quality Assurance, review Site Corrective and Action Plans (SCAPAs), Corrective and Action Plans (CAPAs) and Site Audits
Support the Edgewise clinical study lead in managing progress of assigned studies by tracking regulatory submissions and approvals, recruitment and enrollment and other tasks as assigned
Proactively review electronic data capture (EDC) for completion and to identify issues and generate queries. Identify and monitor risks and decisions at the study level and implementation of mitigation strategies. Identify potential operational challenges, and in collaboration with senior team members, provide guidance and solutions to ensure study execution remains on track
Contribute to drafting Standard Operating Procedures (SOPs) and adhere to Clinical Operations processes and SOPs to ensure studies are "inspection ready" at all times; may be involved in regulatory inspections by preparing for and attending the inspections
Responsible for the oversight of assigned vendors
Collaborate with internal teams (e.g. Clinical Operations, Regulatory Affairs, Data Management, Medical Monitoring, CMC, etc) to ensure seamless trial execution and provide regular study updates to the appropriate internal stakeholders
May be accountable for reviewing site or vendor invoicing and financial management in accordance with the clinical trial agreement / scope of work
Support TMF activities as required (e.g. review of TMF index, document provision, etc.)
Support onboarding and mentoring of new department members
Qualification
Required
At least 4+ years of relevant clinical operations experience and a BS or BA (Life Sciences)
Minimum 4 years of independent on-site monitoring experience (across all visit types and inclusive of remote monitoring), with at least 3 years cardiac study experience in a pharmaceutical sponsor environment preferred (global pharma or biotech preferred)
Excellent attention to detail, verbal, written, interpersonal and presentation skills are required
Must be familiar with routine medical/scientific terminology
Proficiency with MS Office required (inclusive of PPT); Smart Sheet proficiency desirable
Knowledge of FDA, ICH Guidelines, and GCPs governing the conduct of clinical trials is required
Must be able to participate in departmental or interdepartmental strategic initiatives under general supervision
Highly productive, engaged and accountable
Team-player desiring to work in a fast-moving, dynamic start-up environment
Preferred
3 years cardiac study experience in a pharmaceutical sponsor environment preferred (global pharma or biotech preferred)
Smart Sheet proficiency desirable
Benefits
Health benefits
A discretionary bonus plan
Stock option grants
A stock purchase plan
A 401(k) with match
Paid time off
Company
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Funding
Current Stage
Public CompanyTotal Funding
$738.5MKey Investors
Viking Global Investors
2025-04-02Post Ipo Equity· $200M
2024-01-19Post Ipo Equity· $240M
2022-09-13Post Ipo Equity· $138M
Leadership Team
Recent News
2026-01-14
MarketScreener
2025-12-25
Company data provided by crunchbase